Yoshihiro Kawaoka

This inventor holds 67 USPTO granted patents and 23 published patent applications, plus 5 CIPO patents and 12 EPO patents, primarily in Influenza Vaccine Development (CPC class C12N). Top assignees: Wisconsin Alumni Research Foundation, The University of Tokyo, Flugen, Inc.. Active years: 2005-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshihiro Kawaoka. Retrieved from https://idiyas.com/inventor/yoshihiro-kawaoka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 67 (Patent Applications = 23)

% Patents Active = 77.6

CIPO Patents = 5

EPO Patents = 12 (Patent Applications = 14)

Average Co-Inventor Count = 2.1

ph-index = 18

Forward Citations = 984(Granted Patents)

Forward Citations (Not Self Cited) = 76(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Madison, WI (US) (2005 - 2014)
Middletown, WI (US) (2009 - 2014)
Middleton, WI (US) (2007 - 2024)

Company Filing History:

66 out of 4,243

Wisconsin Alumni Research Foundation

patents

7 out of 1,358

The University of Tokyo

where one patent can have more than one assignee

Years Active: 2005-2025

Loading Chart...

Areas of Expertise:

Influenza Viruses

Recombinant Vaccines

Vaccine Development

PB2 Gene

HA Stabilization

NA Stabilization

Immune Responses

Filovirus Vaccine

Humanized Cell Line

Genetic Stability

Virus-Like Particles

Attenuated Vaccines

67 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12410409 - Influenza viruses with mutant PB2 gene segment as live attenuated vaccines (2025-09-09),

2. 12365880 - Recombinant influenza viruses with stabilized NA (2025-07-22),

3. 12364748 - Influenza B virus replication for vaccine development (2025-07-22),

4. 12343390 - Recombinant biologically contained filovirus vaccine (2025-07-01),

5. 12290562 - Recombinant multivalent influenza viruses (2025-05-06),

6. 12258557 - Humanized cell line (2025-03-25),

7. 12251436 - Recombinant influenza viruses with stabilized HA for replication in eggs (2025-03-18),

8. 12144857 - Vectors for eliciting immune responses to non-dominant epitopes in the hemagglutinin (HA) protein (2024-11-19),

9. 12122807 - Influenza virus replication for vaccine development (2024-10-22),

10. 12076387 - Vaccines comprising mutant attenuated influenza viruses (2024-09-03),

11. 11851648 - Humanized cell line (2023-12-26),

12. 11807872 - Recombinant influenza viruses with stabilized HA for replication in eggs (2023-11-07),

13. 11802273 - Mutations that confer genetic stability to additional genes in influenza viruses (2023-10-31),

14. 11739303 - Recombinant influenza viruses with stabilized NA (2023-08-29),

15. 11390649 - Influenza virus replication for vaccine development (2022-07-19),

Title: Yoshihiro Kawaoka: Pioneering Inventor from Middleton, WI

Introduction: Yoshihiro Kawaoka is a renowned inventor based in Middleton, Wisconsin, known for his groundbreaking contributions to the field of virology and vaccine development.

Latest Patents: Kawaoka holds several patents related to novel vaccine technologies and antiviral treatments, showcasing his innovative approach to combating infectious diseases.

Career Highlights: With an illustrious career spanning several decades, Kawaoka has held prominent positions at leading research institutions and universities, where he has spearheaded numerous research projects that have significantly advanced our understanding of viral pathogens.

Collaborations: Throughout his career, Kawaoka has collaborated with top scientists, researchers, and pharmaceutical companies worldwide, fostering a culture of innovation and knowledge-sharing in the scientific community.

Conclusion: Yoshihiro Kawaoka's relentless pursuit of scientific excellence and his commitment to innovation continue to inspire the next generation of inventors and researchers in the field of virology.

Profile summary based on public USPTO records.